Tumor necrosis factor-a enhances antitumor effects of radiation against glioma xenografts

Oncology Research

Volumn 9, Issue 5, 1997, Pages 217-227

  Gridley, Daila S ^a   Archambeau, John O ^a   Andres, Melba A ^a   Mao, Xiao Wen ^a   Wright, Kenneth ^a   Slater, James M ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brain tumor; Glioblastoma; Radiation; Tnf a; Xenograft

Indexed keywords

DNA; RADIOSENSITIZING AGENT; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BLOOD; BODY WEIGHT; BRAIN TUMOR; CANCER TRANSPLANTATION; CYTOLOGY; DNA REPLICATION; DRUG EFFECT; GLIOMA; HUMAN; LEUKOCYTE COUNT; MOUSE; NON-PROGRAMMATIC; NUDE MOUSE; PATHOLOGY; RAT; SPLEEN; XENOGRAFT;

NON-PROGRAMMATIC;

ANIMALS; BODY WEIGHT; BRAIN NEOPLASMS; DNA REPLICATION; DNA, NEOPLASM; GLIOMA; HUMANS; LEUKOCYTE COUNT; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; RADIATION-SENSITIZING AGENTS; RATS; RECOMBINANT PROTEINS; SPLEEN; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTATION, HETEROLOGOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030630693     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Wingo, P. A.; Tony, T.; Bolden B. A. Cancer statistics. CA Cancer J. Clin. 45:8-30; 1995.
2. Salcman, M.; Kaplan, R. Intracranial tumors in adults. In: Moosa, A. R.; Schimpff, S. C.; Robson, M. C., eds. Comprehensive textbook of oncology, 2nd ed., vol. II. Baltimore, MD: Williams & Wilkins; 1991:1339-1352.
3. Bartsch, H. H.; Pfizenmaier, K.; Schröder, M.; Nagel, G. A. Intralesional application of recombinant human tumor necrosis factor a induces local tumor regression in patients with advanced malignancies. Eur. J. Cancer Clin. Oncol. 25:287-291; 1989.
4. Hellman, S.; Weichselbaum, R. R. Radiation oncology and the new biology. Cancer J. Sei. Am. 1:174-179; 1995.
5. Pfreundschuh, M. O.; Steinmetz, H. T.; Tuschen, R.; Schenk, V.; Diehl, V.; Schaadt, M. Phase I study ofintratumoral application of recombinant human tumor necrosis factor. Eur. J. Cancer Clin. Oncol. 25:379-388; 1989.
6. Tada, M.; Sawamura, Y.; Sakuma, S.; Suzuki, K.; Ohta, H.; Aida, T.; Abe, H. Cellular and cytokine responses of the human central nervous system to intracranial administration of tumor necrosis factor or for the treatment of malignant gliomas. Cancer Immunol. Immunother. 36:251-259; 1993.
7. Watanabe, N.; Yamauchi, N.; Maeda, M.; Neda, H.; Tsuji, Y.; Okamoto, T.; Tsuji, N.; Akiyama, S.; Sasaki, H.; Niitsu, Y. Recombinant human tumor necrosis factor causes regression in patients with advances malignancies. Oncology 51: 360-365; 1994.
8. Wright, J. L.; Merchant, R. E. Blood-brain barrier changes following intracerebral injection of human recombinant tumor necrosis factor-alpha in the rat. J. Neurooncol. 20:17-25; 1994.
9. Yamasaki, T.; Moritake, K.; Paine, J. T.; Fukuda, M.; Ohta, F.; Naitoh, H. Intratumoral administration of tumor necrosis factor-alpha for malignant glioma -two case reports. Neurol. Med. Chir. Tokyo 34:216-220; 1994.
10. Carswell, E. A.; Old, L. J.; Rüssel, R. L.; Green, M.; Williamson, B. An endotoxin induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sei. USA 72:3600-3670; 1975.
11. Old, L. J. Antitumor activity of microbial products and tumor necrosis factor. In: Bonavida, B.; Gifford, G. E.; Kircher, H., eds. Tumor necrosis factor/cachectin and related cytokines. Basel, Switzerland: S. Karger; 1988:7-19.
12. Old, L. J. Tumor necrosis factor. Science 230:630-634; 1985.
13. Sugarman, H. J.; Aggarwal; Mass, P. E.; Figari, I. S.; Palladino, M. A., Jr.; Shepard, H. M. Recombinant human tumor necrosis factor: Effects on proliferation of normal and transformed cells in vitro. Science 230:943-945; 1985.
14. Rubin, B. Y.; Smith, L. J.; Hellerman, G. R.; Lunn, R. M.; Richardson, N. K.; Andersen, S. L. Correlation between the anticellular and DNA-fragmentation activities of TNF. Cancer Res. 48:6006-6010; 1988.
15. Vamauchi, N.; Karizana, H.; Watanabe, H.; Neda, H.; Maeda, M.; Nutsu, Y. Intracellular hydro.xyl radical production induced by recombinant human tumor necrosis factor. Cancer Res. 49:1671-1675; 1989.
16. Zimmerman, R. J.; Chan, A.; Leadon, S. A. Oxidative damage in murine tumor cells treated in vilro by recombinant human TNF. Cancer Res. 49:1644-1648; 1989.
17. Hallahan, D. E.; Beckett, M. A.; Kufe, D.; Weichselbaum, R. R. The interaction between recombinant human tumor necrosis factor and radiation in 13 human tumor cell lines. Int. J. Radiât. Oncol. Biol. Phys. 19:69-74; 1990.
18. Hallahan, D. E.; Subbulakshmi, V.; Sherman, M. L.; Huberman, E.; Kufe, D. W.; Weichselbaum, R. R. Tumor necrosis factor gene expression is mediated by protein kinase C following activation by ionizing radiation. Cancer Res. 51:45654569; 1991.
19. Weichselbaum, R. R.; Beckett, M. A.; Simon, M. A.; McCauley, C.; Haraf, D.; Awan, A.; Samuels, B.; Nachman, J.; Dritschilo, A. In vitro radiobiological parameters of human sarcoma cell lines. Int. J. Radiât. Oncol. Biol. Phys. 15: 937-942; 1988.
20. Weichselbaum, R. R.; Dahlberg, W.; Beckett, M. A.; Karrison, T.; Miller, D.; Clark, J.; Ervin, T. J. Radiation-resistant and repair-proficient human tumor cells may be associated with radiotherapy failure in head and neck cancer patients. Proc. Nail. Acad. Sei. USA 83:2684-2688; 1986.
21. Langley, R. E.; Palayoor, S. T.; Coleman, C. N.; Bump, E. A. Modifiers of radiation-induced apoptosis. Radiation Res. 136:320-326; 1993.
22. Olive, P. L.; Frazer, G.; Banath, J. P. Radiation-induced apoptosis measured in TK6 human B lymphoblast cells using the comet assay. Radiât. Res. 136:130-136; 1993.
23. Stephens, L. C.; Ang, K. K.; Schultheiss, T. E.; Milas, L.; Meyn, R. E. Apoptosis in irradiated murine tumors. Radial. Res. 127:308-316; 1991.
24. Tartaglia, 1. A.; Ayres, T. M.; Wong, G. H.; Goeddel, D. V. A novel domain within the 55kd TNF receptor signals cell death. Cell 74:845-853; 1993.
25. Warters, R. L. Radiation-induced apoptosis in a murine T-cell hybridoma. Cancer Res. 52:883-890; 1992.
26. Yamada.T.; Ohyama, H. Radiation-induced interphase death of rat thymocytes is internally programmed. Int. J. Radial. Biol. 53:65-75; 1988.
27. Jams, W. D.; Grant, S.; Kolesnick, R. N. Ceramide and ihe induclion of apoplosis. Clin. Cancer Res. 2:1-6; 1996.
28. Gridley, D. S.; Hammond, S. N.; Liwnicz, B. H. Tumor necrosis factor-ex augments radialion effecis againsl human colon tumor xenografts. Anlicancer Res. 14:1107-1112; 1994.
29. Gridley, D. S.; Andres, M. L.; Garner, C.; Mao, X. W.; Slaler, J. M. Evaluation of TNF-a effects on radiation efficacy in a human lung adenocarcinoma model. Oncol. Res. 8: 485-493;1997.
30. Hallahan, D. E.; Yokes, E. E.; Rubin, S. J.; O'Brien, S.; Samuels, B.; Vijaykumar, S.; Kufe, D. W.; Phillips, R.; Weichselbaum, R. R. Phase I dose-escalalion sludy of lumor necrosis faclor-a and concomilanl radation therapy. Cancer J. 1:204-209; 1995.
31. Mauceri, H. J.; Hanna, N. N.; Wayne, J. D.; Hallahan, D. E.; Hellman, S.; Weichselbaum, R. R. Tumor necrosis factor a (TNF-a) gene therapy targeted by ionizing radiation selectively damages lumor vasculalure. Cancer Res. 56:4311-4314; 1996.
32. Seung, L. P.; Mauceri, H. J.; Becken, M. A.; Hallahan, D. E.; Hellman, S.; Weichselbaum, R. R. Genelic radiotherapy overcomes tumor resistance to cytoloxic agenls. Cancer Res. 55:5561-5565; 1995.
33. Benda, P.; Lighlfool, J.; Sato, G.; Levine, L.; Sweet, W. Differentiated rat glial cell strain in tissue culture. Science 161: 370-371; 1968.
34. Auer, R.; Del Maestro, R. F.; Andersen, R. A simple and reproducible experimental in vivo glioma model. Can. J. Neurol. 8:325-331; 1981.
35. Stewart, P. A.; Hayakawa, K.; Hayakawa, E.; Farrell, C. L.; Del Maestro, R. F. A quantitative study of blood brain barrier permeability ultrastructure in a new glioma model. Acta Neuropathol. (Berl.) 67:96-102; 1985.
36. Hallahan, D. E.; Haimovitz-Friedman, A.; Kufe, D. W.; Fuks, Z.; Weichselbaum, R. R. The role of cytokines in radiation oncology. In: DeVita, V. T.; Hellman, S.; Rosenberg, S. A., eds. Important advances in oncology 1993. Philadelphia: J. B. Lippincott Company; 1993:71-80.
37. Wong, G. H. W.; McHugh, T.; Weber, R.; Goeddel, D. V. Tumor necrosis factor a selectively sensitizes human immunodeficiency virus-infected cells to heat and radiation. Proc. Natl. Acad. Sei. USA 88:4372-4376; 1991.
38. Wan, C. P.; Myung, E.; Lau, B. H. S. An automated microfluorometric assay for monitoring oxidative burst activity of phagocytes. J. Immunol. Methods 159:131-138; 1993.
39. Chapman, P. B.; Lester, T. J.; Casper, E. S.; Gabrilove, J. L.; Wong, G. Y.; Kempin, S. J.; Fletcher, Starnes, H.; Sher\vin, S. A.; Old, L. J.; Oetigen, H. F. Clinical pharmacology of recombinant tumor necrosis factor in patients with advanced cancer. J. Clin. Oncol. 5:1942-1951; 1987.
40. Feinberg, B.; Kurzrock, R.; Talpaz, M.; Blick, M.; Saks, S.; Gutterman, J. U. A phase I trial of intravenously administered tumor necrosis factor-alpha in cancer patients. J. Clin. Oncol. 6:1328-1334; 1988.
41. Gamm, H.; Lindemann, A.; Martelsmann, R.; Herrmann, F. Phase 1 trial of recombinant human tumor necrosis factor-a in patients with advanced malignancy. Eur. J. Cancer 27:856863;1991.
42. Sarraf, C. E. Tumor necrosis factor and cell death in tumors (review). Int. J. Oncol. 5:1333-1339; 1994.
43. Hallahan, D. E.; Mauceri, H. J.; Seung, L. P.; Dunphy, E. J.; Wayne, J. D.; Hanna, N. N.; Toledano, A.; Hellman, S.; Kufe, D. W.; Weichselbaum, R. R. Spatial and temporal control of gene therapy using ionizing radiation. Nat. Med. 1: 786-791:1995.
44. Dinarello, C. A. Inflammatory consequences of cytokines in infectious diseases. In: Oppenheim, J. J.; Rossio, J. L.; Gearing, A. J. H., eds. Clinical applications of cytokines. New York: Oxford University Press; 1993:35-42.
45. Larrick, J. W.; Wright, S. C. Cytotoxic mechanisms of tumor necrosis factor-a. FASEB J. 4:3215-3223; 1990.
46. Braun, D. P.; Penn, R. D.; Flannery, A. M.; Harris, J. E. Immunoregulatory cell function in peripheral blood leukocytes of patients with intracranial gliomas. Neurosurgery 10: 203-209; 1982.
47. Rudenko, V. A.; Lisianyl, N. I.; Radzievskii, A. A. Lymphocyte subpopulations and their functional activity in patients with brain tumors. Vrach. Delo 9:91-94; 1991.
48. Luscinskas, F. W.; Brock, A. F.; Arnaout, M. A.; Gilbrone, M. A. Endolhelial leukocyte adhesion molecule-l-dependent and leukocyte (CDH/CD18)-dependent mechanisms contribute to polymorphonuclear leukocyte adhesion to cytokineactivated human vascular endothelium. J. Immunol. 142: 2257-2263; 1989.
49. Tedder, T. F.; Steeber, D. A.; Chen, A.; Engel, P. The selectins: Vascular adhesion molecules. FASEB J. 9:866-873; 1995.
50. Van der Poll, T.; van Deventer, S. J. H.; Hack, C. E.; Wolbink, G. J.; Aarden, L. A.; Bueller, H. R.; Ten Cate, J. W. Effects on leukocytes following injection of tumor necrosis factor into healthy humans. Blood 79:693-697; 1992.
51. Descamps-Latscha, B.; Herbelin, A.; Nguyen, A. T.; RouxLombard, P.; Zingraff, J.; Moynot, A.; Verger, C.; Dahmane, D.; deGroote, D.; Jungers, P.; Dayer, J. M. Balance between 1L-10, TNF-a, and their specific inhibitor in chronic renal failure and maintenance dialysis. J. Immunol. 154:882892;1995.
52. Jansen, J.; van der Poll, T.; Levi, M.; Cate, H. T.; Gallati, H.; Cate, J. W. T.; van Deventer, S. J. H. Inhibition of the release of soluble tumor necrosis factor receptors in experimental endotoxemia by an anti-tumor necrosis factor-a antibody. J. Clin. Immunol. 15:45-50; 1995.
53. Peetre, C.; Thysell, H.; Grubb, A.; Olsson. I. A tumor necrosis factor binding protein is present in human biological fluids. Eur. J. Haematol. 41:414-419; 1988.
54. Aederka, D.; Engelmann, H.; Wallach, D. Serum levels of TNF receptors in patients with metastatic disease. Cancer Res. 51:5602-5605;1991.
55. Olsson, I.; Lantz, M.; Nilsson, E.; Peetre, C.; Thysell, H.; Grubb, A.; Adolf, G. Isolation and characterization of a tumor necrosis factor binding protein from urine. Eur. J. Haematol. 42:270-275; 1989.
56. Spriggs, D. R.; Sherman, M. L.; Michie, H.; Arthur, K. A.; Imamura, K.; Wilmore, D.; Frei, E., Ill; Kufe, D. W. Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion: A phase 1 and pharmacologie study. J. Natl. Cancer Inst. 80:1039-1044; 1988.
57. Sabatini, M.; Yates, A. J.; Garrett, R.; Chavez, J.; Dünn, J.; Bonewald, L.; Mundy, G. R. Increased production of tumor necrosis factor by normal immune cells in a model of the humoral hypercalcemia of malignancy. Lab. Invest. 63:676681; 1990.
58. Yoneda, T.; Alsina, M. M.; Chavez, J. B.; Bonewald, L.; Nishimura, R.; Mundy, G. R. Evidence that tumor necrosis factor plays a pathogenetic role in the paraneoplastic syndromes of cachexia, hypercalcemia and leukocytosis in a human tumor in nude mice. J. Clin. Invest. 87:977-985; 1991.
59. Constam, D.; Philipp, J.; Malipiero, U. V.; Ten Duke, P.; Schachner, M.; Fontana, A. Differential expression of transforming growth factor-l, -02, and -03 by glioblastoma cells, astrocytes, and microglia. J. Immunol. 148:1404-1410; 1992.
60. Tsunawaki, S.; Sporn, M.; Ding, A.; Nathan, C. Deactivation of macrophages by transforming growth factor-0. Nature 34: 260-262;1988.
61. Spriggs, D. R.; Jaffe, H. S. Pathophysiologic effects of tumor necrosis factor therapy on cancer patients. In: Oppenheim, J. J.; Rossio, J. L.; Gearing, A. J. H., eds. Clinical applications of cytokines. New York: Oxford University Press; 1993:167-170.
62. Kane, C. J. M.; Hebda, P.; Mansbridge, J. N.; Hanawalt, P. C. Direct evidence for spatial and temporal regulation of transforming growth factor beta 1 expression during cutaneous wound healing. J. Cell. Physiol. 148:157-173; 1991.
63. Blasberg, R. G.; Shapiro, W. R.; Molnar, P.; Patlak, C. S.; Fenstermacher, J. D. Local blood-to-tissue transport in Walker 256 metastatic brain tumors. J. Neurooncol. 2:205218; 1984.
64. Fross, R. D.; Warnke, P. C.; Groothuis, D. R. Blood flow and blood-to-tissue transport in 9L gliosarcomas: The role of the brain tumor model in drug delivery research. J. Neurooncol. 11:185-197; 1991.
65. Vriesendorp, F. J.; Pesgram, C.; Bigner, D. D.; Groothuis, D. R. Concurrent measurements of blood flow and transcapillary transport to xenotransplanted human gliomas in immunesuppressed rats. J. Natl. Cancer Inst. 79:123-130; 1984.
66. d'Avela, D.; Cicciarello, R.; Albiero, F.; Mesiti, M.; Gagliardi, M. E.; Russi, E.; d'Aquino, A.; Tomasello, F.; d'Aquino, S. Quantitative study of blood-brain barrier permeability changes after experimental whole-brain radiation. Neurosurgery 30:30-34; 1992.
67. Lo, E. H.; Frankel, K. A.; Steinberg, G. K.; DeLAPaz, R. L.; Fabrikant, J. L. High-dose single-fraction brain irradiation: MR1, cerebral blood flow, electrophysiological, and histological studies. Int. J. Radial. Oncol. Biol. Phys. 22:47-55; 1992.